Paul K Laikind Insider Trading
Get free email notifications about insider trading for Paul K Laikind.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Paul K Laikind. Paul K Laikind is an Chief Executive Officer in METABASIS THERAPEUTICS INC ($MBRX) and a Director in METABASIS THERAPEUTICS INC ($MBRX).
Address: 11119 NORTH TORREY PINES ROAD LA JOLLA 92037 CA
Companies in which Paul K Laikind is an Insider
METABASIS THERAPEUTICS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Paul K Laikind: Director, Chief Executive Officer
Holdings: 707,220 shares
Current Value: $1,272,996
Latest Transaction: Jun 25 2009
$MBRX Market Capitalization: $18.08M
$MBRX Previous Close: $1.80
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Paul K Laikind
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 25 2009 | MBRX | METABASIS THERAPEU ... | Laikind Paul K | Director | Option Exercise | A | 0.41 | 5,000 | 2,050 | 5,000 | |
Nov 19 2008 | MBRX | METABASIS THERAPEU ... | Laikind Paul K | Chief Executive Off ... | Buy | P | 0.53 | 100 | 53 | 707,220 | 707.1 K to 707.2 K (+0.01 %) |
Nov 19 2008 | MBRX | METABASIS THERAPEU ... | Laikind Paul K | Chief Executive Off ... | Buy | P | 0.49 | 100 | 49 | 707,120 | 707 K to 707.1 K (+0.01 %) |
Nov 19 2008 | MBRX | METABASIS THERAPEU ... | Laikind Paul K | Chief Executive Off ... | Buy | P | 0.57 | 837 | 477 | 707,020 | 706.2 K to 707 K (+0.12 %) |
Nov 19 2008 | MBRX | METABASIS THERAPEU ... | Laikind Paul K | Chief Executive Off ... | Buy | P | 0.55 | 100 | 55 | 706,183 | 706.1 K to 706.2 K (+0.01 %) |
Nov 19 2008 | MBRX | METABASIS THERAPEU ... | Laikind Paul K | Chief Executive Off ... | Buy | P | 0.75 | 963 | 722 | 706,083 | 705.1 K to 706.1 K (+0.14 %) |
Nov 19 2008 | MBRX | METABASIS THERAPEU ... | Laikind Paul K | Chief Executive Off ... | Buy | P | 0.74 | 200 | 148 | 705,120 | 704.9 K to 705.1 K (+0.03 %) |